Prescription drug spending in the United States is projected to rise sharply again in 2026, intensifying scrutiny of every intermediary involved in the pharmaceutical supply chain. Pharmacy benefit managers (PBMs), which negotiate with drug manufacturers and administer pharmacy benefits on behalf of employers and insurers, have become a primary target for legislative intervention.PBMs secure discounts […]
